Pricing Log in Create free account
Saturday 17 October 2026 Export RVTY’s income statement to Excel — free account

Revvity Inc.

RVTY Healthcare Diagnostics & Research

Revvity Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 3.67% from fiscal 2024. In the quarter to June 2026, revenue grew 1.31%, EPS grew 2.17%, free cash flow grew 59.3% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.

152.64 2.07 −1.34%
Market cap
$17.3B
P/E
72.7×
Fwd P/E
37.5×
Dividend yield
0.18%
F-score
6/9
Altman Z
2.49
Beneish M
−2.45
Dividend safety
80/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Revvity Inc. (RVTY) Net income

Alert me on Net income

Revvity Inc.'s net income for fiscal 2025 was $241.2M, down 10.8% from $270.4M in fiscal 2024. Over the twelve months to 30 June 2026 it was $237.6M. Over the past ten years it has ranged from $212.4M (fiscal 2015) to $943.2M (fiscal 2021); the current reading is higher than 45% of that period. Revvity Inc. ranks 12th of 52 Diagnostics & Research companies by net income.

Net income, annual

Embed this chart

Annual newest first

Period Net income Change
FY2025 $241.2M (10.79%)
FY2024 $270.4M (60.99%)
FY2023 $693.1M 21.77%
FY2022 $569.2M (39.65%)
FY2021 $943.2M 29.57%
FY2020 $727.9M 219.87%
FY2019 $227.6M (4.36%)
FY2018 $237.9M (18.69%)
FY2017 $292.6M 24.90%
FY2016 $234.3M 10.30%

Quarterly newest first

Period Net income Change
Jun 2026 $51.8M 27.27%
Mar 2026 $40.7M (58.60%)
Dec 2025 $98.4M 110.85%
Sep 2025 $46.7M (13.52%)
42 more quarters

Against its own ten years

Low $212.4M High $943.2M
Ten-year median $270.4M
Current reading's percentile 45

Net income against peers

Company Net income
DGX Quest Diagnostics Incorporated compare $1.1B
LH Labcorp Holdings Inc. compare $1.0B
MEDP Medpace Holdings, Inc. compare $491.5M
QGEN QIAGEN N.V. compare $409.3M
RVTY Revvity Inc. $237.6M
ICLR ICON PLC compare $42.3M
TWST Twist Bioscience Corporation compare −$136.7M
CRL Charles River Laboratories International, Inc. compare −$236.3M
GH Guardant Health, Inc. compare −$453.4M

What Net income is

Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.

Reported line item

The full definition of Net income →

More on RVTY